Several key stocks fell significantly due to company-specific issues. Intuitive Surgical's shares dropped 14.15% despite strong earnings because of slower growth in surgical procedures, impacting related leveraged ETFs. REGENXBIO's stock fell 11.7% after announcing a public share offering, raising dilution concerns. Silvaco Group's shares declined 11.48% amid a shareholder lawsuit investigation, adding market uncertainty. These events highlight how specific news can sharply affect stock prices and related ETFs.
Intuitive Surgical reported strong Q2 earnings with adjusted EPS of $2.80, surpassing analyst expectations due to high demand for its da Vinci robotic surgical systems. Despite the positive results, the stock dropped 12% in premarket trading after th...
Intuitive Surgical reported Q2 revenue of $2.89 billion and adjusted earnings of $2.80 per share, beating analyst estimates. However, shares fell 11% as US procedure growth slowed to 12% from 14% in Q1, attributed to deferred treatments and changes i...
Intuitive Surgical reported strong Q2 2026 results, with EPS of $2.80 beating estimates by nearly 13% and revenue reaching $2.89 billion, surpassing forecasts. This marks the fourth consecutive quarter the company has exceeded earnings expectations, ...
Intuitive Surgical announced a 19% revenue increase to $2.89 billion in Q2 2026, driven by a 16% rise in worldwide procedures and higher system placements. The company placed 468 da Vinci surgical systems, including 246 da Vinci 5 models, and grew it...
Intuitive Surgical is scheduled to release its Q2 2026 earnings report, with analysts forecasting an EPS of $2.48 and revenue of $2.83 billion, up from $2.44 billion last year. The company is known for its da Vinci robotic surgical systems and has a ...
